Related Experiment Video
Updated: Oct 24, 2025
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.1K
Burnout Among Health System Pharmacists: Presentation, Consequences, and Recommendations
Lalita Prasad-Reddy1,2,3, Rola Kaakeh4, Bryan C McCarthy5
1Chicago State University, IL, USA.
Hospital Pharmacy
|August 12, 2021
Summary
Healthcare burnout negatively impacts wellbeing, productivity, and patient care. Health-system pharmacy leaders must address pharmacist burnout by identifying risks and fostering resilience.
Area of Science:
- Healthcare Management
- Occupational Health
- Pharmacy Practice
Background:
- Burnout is a significant and growing problem in healthcare settings.
- Healthcare burnout is linked to reduced personal wellbeing, lower productivity, increased costs, and diminished patient care quality.
- Expanding roles for pharmacists necessitate attention to burnout within health systems.
Purpose of the Study:
- To highlight the importance of recognizing and addressing burnout among pharmacists.
- To outline key strategies for health-system pharmacy leaders to mitigate burnout.
- To emphasize the need for proactive measures to support pharmacist wellbeing and resilience.
Main Methods:
- This section is not detailed in the provided abstract.
- The abstract discusses the association of burnout with various negative outcomes.
- It suggests areas for intervention by pharmacy leadership.
Main Results:
- The abstract does not present specific quantitative results.
- It identifies burnout as a multifaceted issue with broad implications.
- The text implies that addressing burnout can lead to improved outcomes.
Conclusions:
- Health-system pharmacy leaders must be aware of burnout's risk factors and identification methods.
- Implementing coordinated efforts to foster wellbeing, manage responsibilities, ensure transparency, and build relationships is crucial.
- Proactive management of pharmacist burnout is essential for individual and organizational success.
Keywords:
clinical serviceseducationhuman resourcesmanagementresidency training / programsstaff developmentMore Related Videos
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
17.4K
12:22Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
Published on: July 1, 2015
23.9K
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
830
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
830
01:20Desensitization and Tachyphylaxis
2.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.5K
01:19Pharmacovigilance
1.2K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
31
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
31
01:15Drug Dosing: Geriatric Patients
48
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
48
01:26Psychosis: Goals of Pharmacotherapy
276
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
276